Biomarker Development Unit for cancer detection
Official title: Biomarker Developmental Unit
Funded at Arizona State University-Tempe Campus · NIH-11412529 · Data updated 2026-11-12
A patient-facing program to develop and validate blood biomarkers that could help detect lung and ovarian cancer early using accessible antibody-based tests.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | September 1, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $396,983 |
| NIH project number | 5U2CCA271903-05 |
| Project ID | NIH-11412529 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals at risk for lung or ovarian cancer or those undergoing cancer screening who could contribute samples for assay validation.
✕Less likely to help
People without cancer or with non-cancerous conditions may not directly benefit from these tests.
What this research studies
This grant supports converting research-based antibody tests into clinically usable assays and participating in collaborative validation studies. It focuses on detecting early cancer signals through serological markers such as autoantibodies and antibodies against tumor proteins. The work is conducted through ASU's Biomarker Characterization Center in partnership with a diagnostics company to ensure the tests are practical for clinical use. By validating these assays on human samples, the project aims to improve early cancer detection options for patients.
Why it matters
Potential benefit: If successful, patients could benefit from earlier and more accurate cancer detection through blood tests.
How similar studies have gone: Previous biomarker validation efforts have shown that blood-based antibody markers can aid early cancer detection when properly validated.
Where this research is happening
-
Arizona State University-Tempe Campus
Scottsdale, United States Active
Researchers
- Principal investigator: Stengelin, Martin — Arizona State University-Tempe Campus
- Study coordinator: Stengelin, Martin
Related research
Other NIH-funded projects on the same topics.
-
Understanding how herpesviruses move and exit cells (focus on HSV-1 and PRV)
Scientists are studying how herpesviruses travel inside nerve cells and exit at the right spots, which could lead to better prevention and treatment of infections in people and animals.
-
Whole Protein Arrays to Find Antibodies Linked to Islet Autoimmunity in a Big Birth Cohort
This NIH grant aims to map antibodies against many microbes in children from the TEDDY study to understand what infections might be linked to the development of type 1 diabetes.
-
Climate heat and Alzheimer's risk in older adults
Heat exposure may influence brain health and dementia risk in older adults living in the United States.
-
Certified Cancer Registry Extraction with Proof-Certified Trust
A new AI-powered system helps cancer registries extract standardized data from medical records more accurately and with formal proofs to ensure trust.
-
Demystifying E. coli ecosystems with synthetic microbial communities
A project builds controlled, synthetic E. coli communities to uncover how different interactions shape colony behavior and health-related outcomes.
-
Aflatoxin exposure and child growth in Guatemala
A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.